Article

South China Morning Post on 2020-09-30 15:37

Vaccines alone won’t be enough to fight Covid-19, Novartis CEO says

Vas Narasimhan says significant supplies of highly effective vaccines probably won’t be available until the end of next year.

Europe

Vas Narasimhan

Related news

Novartis CEO Vas Narasimhan On The Price Of Gene Therapies: 'It's A Challenge We Have To Solve'Forbes
Europe , Switzerland
WNovartis names drugs chief as CEO whitecourtpress.com
The CEO of Novartis on Developing Drugs During a Pandemic Wired.com
Asia , Africa , Latin America , Europe , Massachusetts
There Won’t Be Enough COVID-19 Vaccines—And The US Can’t Decide Who Gets It First observer.com
Europe , Smilyan , Russia , Argentina , Buenos Aires
FNovartis CEO: We need a different approach to drug discovery fortune.com
Basel , Switzerland
Novartis CEO defends call to withhold data from FDA nwaonline.com
Europe , Japan , United States
SNew coronavirus variants have changed the game, and vaccines won’t be enough scmp.com
California
COVID vaccines are not enough for Omicron variant, warns BioNTech CEO euronews
Europe , South Africa , United Kingdom , France , Germany
BVaccines won’t be enough blogs.timesofisrael.com
Tel Aviv , Puerto Rico , Greece , Ezulwini , Israel
Vaccines Alone Won’t Beat Ebola The Atlantic
Guinea , Bikoro , Gavi , India , Liberia
MDrugmaker Novartis plays down its deal with Trump’s lawyer, tying it to its former CEO marketwatch.com
Europe , Switzerland , Russia
A Japanese CEO resigned after an employee’s ‘death by overwork.’ Why it won’t be enough.Washington Post
United States , South Korea , Mexico , Turkey , Washington
LGlobal Human Rabies Vaccines Market 2021 Financial Insights, Business Growth Strategies, Trends | Market Players: Sanofi Pasteur?Inc., Medimmune LLC, GlaxoSmithKline Biologicals, Novartis Vaccines …liverpoolstudentmedia.com
Africa , Middle East , Mexico , Brazil , Latin America
MNovartis CEO says Covid is turning into endemic and requires higher pandemic preparedness mvtelegraph.com
Beijing , China , Switzerland
Former Novartis CEO Explains Why His Company Paid Trump Lawyer Michael Cohen $1.2 Million Forbes
Washington , Basel
EEU warns not enough COVID vaccines for all in Europe until 2022 ekathimerini.com
Europe
Novartis calls $US1.2M deal with Trump lawyer's firm a 'mistake'Sydney Morning Herald
Russia , White House , Europe , Switzerland
Why Did Novartis Spend $9 Billion On Gene Therapy? CEO Says: 'A Journey To Focus On Data And Digital'Forbes
Switzerland